Literature DB >> 33025727

A rare presentation of Erdheim Chester disease in a pediatric patient subsequently cured on the LCH III protocol.

Aditya Kumar Gupta1, Abdul Wajid M1, Jagdish P Meena1, Sreedharan T ArunRaj2, Asit Mridha3, Priyanka Naranje4, Rakesh Kumar2, Rachna Seth1.   

Abstract

BACKGROUND: Erdheim Chester disease (ECD) is very rare in pediatrics with no standard treatment guidelines. Here we present the case of a pediatric ECD patient who was cured with a Langerhan cell histiocytosis (LCH) directed chemotherapy protocol. AIM: The aim of the report was to publish this rare presentation of ECD in pediatrics and highlight the complete response obtained to treatment.
METHODS: The details of the patient were extracted by a retrospective review of her clinical records. RESULTS (CASE): An 11 years old girl presented with fever and bone pain. On investigating she had multiple lytic bony lesions scattered throughout her skeleton. A biopsy from one of the bone lesions confirmed the diagnosis to be ECD. ECD is very rare in pediatrics and this case adds to the existing list of 11 previously reported ones. Also, worth mention is the fact that the child presented with isolated skeletal involvement in form of multiple osteolytic lesions. The child was started on the LCH-III protocol on which she achieved a cure.
CONCLUSION: Lytic bone lesions in a child may be present in ECD. A subset of ECD may have good response to LCH like chemotherapy.
© 2020 The Authors. Cancer Reports published by Wiley Periodicals LLC.

Entities:  

Keywords:  Erdheim Chester disease; LCH-III protocol; pediatrics

Year:  2020        PMID: 33025727      PMCID: PMC7941579          DOI: 10.1002/cnr2.1304

Source DB:  PubMed          Journal:  Cancer Rep (Hoboken)        ISSN: 2573-8348


  8 in total

1.  Erdheim-Chester disease in a child.

Authors:  Anna Clerico; Giuseppina Ragni; Carlo Cappelli; Amalia Schiavetti; Michaela Gonfiantini; Stefania Uccini
Journal:  Med Pediatr Oncol       Date:  2003-12

2.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

Review 3.  Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases.

Authors:  C Veyssier-Belot; P Cacoub; D Caparros-Lefebvre; J Wechsler; B Brun; M Remy; B Wallaert; H Petit; A Grimaldi; B Wechsler; P Godeau
Journal:  Medicine (Baltimore)       Date:  1996-05       Impact factor: 1.889

4.  Unusual presentation of Erdheim-Chester disease in a child with acute lymphoblastic leukemia.

Authors:  Archana George Vallonthaiel; Asit Ranjan Mridha; Shivanand Gamanagatti; Manisha Jana; Mehar Chand Sharma; Shah Alam Khan; Sameer Bakhshi
Journal:  World J Radiol       Date:  2016-08-28

Review 5.  Erdheim-Chester disease.

Authors:  Corrado Campochiaro; Alessandro Tomelleri; Giulio Cavalli; Alvise Berti; Lorenzo Dagna
Journal:  Eur J Intern Med       Date:  2015-04-10       Impact factor: 4.487

6.  Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.

Authors:  Paul Milne; Venetia Bigley; Chris M Bacon; Antoine Néel; Naomi McGovern; Simon Bomken; Muzlifah Haniffa; Eli L Diamond; Benjamin H Durham; Johannes Visser; David Hunt; Harsha Gunawardena; Mac Macheta; Kenneth L McClain; Carl Allen; Omar Abdel-Wahab; Matthew Collin
Journal:  Blood       Date:  2017-05-16       Impact factor: 22.113

7.  Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.

Authors:  Helmut Gadner; Milen Minkov; Nicole Grois; Ulrike Pötschger; Elfriede Thiem; Maurizio Aricò; Itziar Astigarraga; Jorge Braier; Jean Donadieu; Jan-Inge Henter; Gritta Janka-Schaub; Kenneth L McClain; Sheila Weitzman; Kevin Windebank; Stephan Ladisch
Journal:  Blood       Date:  2013-04-15       Impact factor: 22.113

8.  A rare presentation of Erdheim Chester disease in a pediatric patient subsequently cured on the LCH III protocol.

Authors:  Aditya Kumar Gupta; Abdul Wajid M; Jagdish P Meena; Sreedharan T ArunRaj; Asit Mridha; Priyanka Naranje; Rakesh Kumar; Rachna Seth
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-06
  8 in total
  1 in total

1.  A rare presentation of Erdheim Chester disease in a pediatric patient subsequently cured on the LCH III protocol.

Authors:  Aditya Kumar Gupta; Abdul Wajid M; Jagdish P Meena; Sreedharan T ArunRaj; Asit Mridha; Priyanka Naranje; Rakesh Kumar; Rachna Seth
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.